Genocea Biosciences, Inc.
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
Last updated:
Abstract:
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
Status:
Grant
Type:
Utility
Filling date:
3 Jan 2018
Issue date:
19 May 2020